Table S1. Data description of TCGA RNA sequencing data. Table S2. List of antibody-drug conjugates. Figure S1. Distribution of tumor sample-specific gene expression in 14 cancer types. Totally 20,531 genes, 519 cell surface marker, and significant cell surface hits (log2Delta > 1 and p-value < 0.01) are illustrated in grey, yellow, and red, respectively. Figure S2. Western blot analysis of the MUC 4, MSLN and SLC7A11 expression on STK11 mutant, restored and wild type cell lines. (A) gene expression on STK11 mutant, restored and wild-type cell lines on 2D culture status and (B) on 3D culture status. (DOCX 1902 kb
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...
Table S2. List of all nonsynonymous coding mutations in six tumor cell lines. (XLSX 84 kb
List of 14 genes overexpressed in melanoma cell lines with a CGAS ≥7 (max 10 % FDR). List of 192 PCC...
Table S1. RNA-sequencing results for tumor tissue (a) or non-malignant lung tissue (b). Differential...
Table S1.The clinical features of the patients. Table S2. Clinical features of the patients from TCG...
Table S1. Growth media for breast cancer cell lines used in study. Table S2. PTEN protein abundance ...
Table S1. Comparison of regulatory T cell marker genes expression levels between the lower-TMB and t...
Characteristics of the microRNA sample set. Table S2: Characteristics of the adenocarcinoma validati...
Table S1. Drug classes in DEPO (database of evidence for precision oncology). Table S2. Sensitive dr...
Gene list. Table S2. Pathway list and genes in the pathway. Table S3. Scale and center data used for...
Stratified analysis TCGA. Table S1 and Table S2: Gene expression-Agilent (ER-pos) (Table S1) and RNA...
Table S1. 48 genes included in the TruSeq Amplicon Cancer Panel (TSACP, Illumina), which includes 21...
Table S1. Clinical characteristics. Table S2. RNA-seq gene function list. Table S3. Gene function an...
Figure S1. The distribution of the expression values for the gene ORMDL3 in the Metabric validation ...
Comparison of the frequency of select mutational events in breast cancer tumours versus cell lines. ...
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...
Table S2. List of all nonsynonymous coding mutations in six tumor cell lines. (XLSX 84 kb
List of 14 genes overexpressed in melanoma cell lines with a CGAS ≥7 (max 10 % FDR). List of 192 PCC...
Table S1. RNA-sequencing results for tumor tissue (a) or non-malignant lung tissue (b). Differential...
Table S1.The clinical features of the patients. Table S2. Clinical features of the patients from TCG...
Table S1. Growth media for breast cancer cell lines used in study. Table S2. PTEN protein abundance ...
Table S1. Comparison of regulatory T cell marker genes expression levels between the lower-TMB and t...
Characteristics of the microRNA sample set. Table S2: Characteristics of the adenocarcinoma validati...
Table S1. Drug classes in DEPO (database of evidence for precision oncology). Table S2. Sensitive dr...
Gene list. Table S2. Pathway list and genes in the pathway. Table S3. Scale and center data used for...
Stratified analysis TCGA. Table S1 and Table S2: Gene expression-Agilent (ER-pos) (Table S1) and RNA...
Table S1. 48 genes included in the TruSeq Amplicon Cancer Panel (TSACP, Illumina), which includes 21...
Table S1. Clinical characteristics. Table S2. RNA-seq gene function list. Table S3. Gene function an...
Figure S1. The distribution of the expression values for the gene ORMDL3 in the Metabric validation ...
Comparison of the frequency of select mutational events in breast cancer tumours versus cell lines. ...
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...
Table S2. List of all nonsynonymous coding mutations in six tumor cell lines. (XLSX 84 kb
List of 14 genes overexpressed in melanoma cell lines with a CGAS ≥7 (max 10 % FDR). List of 192 PCC...